Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
NCT00657202
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Neurofibromatosis Type 1
Cutaneous Neurofibromas
Interventions
DRUG:
Ranibizumab
Sponsor
Massachusetts General Hospital